Trial Profile
Phase I/II Study of Carboplatin in Association With Weekly Oral Topotecan in Patients With Metastatic or Recurrent Cervical Cancer.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 09 Jul 2012
Price :
$35
*
At a glance
- Drugs Topotecan (Primary) ; Carboplatin
- Indications Cervical cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms HYCAR
- 12 May 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
- 12 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Oct 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.